Universidade Federal de São Paulo, Departamento de Medicina Preventiva, São Paulo, SP, Brazil.
Universidade Federal de São Paulo, Departamento de Medicina Preventiva, São Paulo, SP, Brazil.
J Pediatr (Rio J). 2024 Jul-Aug;100(4):367-376. doi: 10.1016/j.jped.2024.01.005. Epub 2024 Apr 3.
To describe the changes in alcohol and drug use by Brazilian adolescents during the COVID-19 pandemic (April-August 2021), and to analyze the relationship between alcohol use changes and psychiatric symptomatology.
A secondary analysis with a longitudinal approach was performed with data from a cluster-randomized controlled trial, conducted in 73 public middle schools in three Brazilian cities, to evaluate the effectiveness of a drug use prevention program. The sample included 535 students (61% girls; M = 15.2 years). Data were collected pre-intervention (February-March 2019), after 9 months (November-December 2019), and after 26 months (April-August 2021), when the students were in their first year of high school. The authors analyzed drug use prevalence (alcohol, binge drinking, tobacco, inhalants, marijuana, cocaine, and crack) in a lifetime, past year, and past month periods, and the association between alcohol use change subsamples with psychiatric symptoms. Logistic regressions were adjusted by sex, age, socioeconomic status, city, and group (control and intervention).
The present findings suggest that the COVID-19 pandemic led to a decrease in past-year substance use and in past-month substance use frequency, despite the gradually increased (but decelerating) prevalence of lifetime use. However, some adolescents initiated, maintained, or increased the frequency of their alcohol use. Mainly, they were more likely to present behavioral problems, as well as symptoms of inattentive hyperactivity, and peer and emotional problems.
Despite the extensive decline in substance use during the pandemic period, these results suggest an association between previous mental health conditions and behavioral risk factors, leading to increased alcohol consumption and behavioral disorders manifestations.
描述巴西青少年在 COVID-19 大流行期间(2021 年 4 月至 8 月)的酒精和药物使用变化,并分析酒精使用变化与精神症状之间的关系。
采用纵向研究的二次分析方法,对在巴西三个城市的 73 所公立中学进行的一项随机对照试验的数据进行分析,以评估一项药物预防计划的效果。该样本包括 535 名学生(61%为女性;M=15.2 岁)。数据采集于干预前(2019 年 2 月至 3 月)、9 个月后(2019 年 11 月至 12 月)和 26 个月后(2021 年 4 月至 8 月),此时学生们正在高中一年级。作者分析了终生、过去一年和过去一个月的药物使用流行率(酒精、狂饮、烟草、吸入剂、大麻、可卡因和快克),以及酒精使用变化亚组与精神症状之间的关联。通过性别、年龄、社会经济地位、城市和组(对照组和干预组)对逻辑回归进行调整。
本研究结果表明,尽管终生使用的流行率逐渐增加(但增速放缓),但 COVID-19 大流行导致过去一年和过去一个月的物质使用减少。然而,一些青少年开始、维持或增加了酒精的使用频率。主要是,他们更有可能出现行为问题,以及注意力不集中、多动、同伴和情绪问题的症状。
尽管在大流行期间药物使用广泛减少,但这些结果表明,先前的心理健康状况和行为风险因素之间存在关联,导致酒精消费增加和行为障碍表现。